Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape

Author:

Georghiou S. B.1,Seifert M.1,Catanzaro D.2,Garfein R. S.1,Valafar F.3,Crudu V.4,Rodrigues C.5,Victor T. C.6,Catanzaro A.1,Rodwell T. C.1

Affiliation:

1. Department of Medicine, University of California, San Diego, La Jolla, California, USA

2. University of Arkansas, Fayetteville, Arkansas, USA

3. Biological and Medical Informatics Research Center, San Diego State University, San Diego, California, USA

4. Microbiology and Morphology Laboratory, Institute of Phthisiopneumology, Chisinau, Moldova

5. Department of Microbiology, P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India

6. Division of Molecular Biology and Human Genetics, Stellenbosch University, Stellenbosch, South Africa

Abstract

ABSTRACT Molecular diagnostic assays, with their ability to rapidly detect resistance-associated mutations in bacterial genes, are promising technologies to control the spread of drug-resistant tuberculosis (DR-TB). Sequencing assays provide detailed information for specific gene regions and can help diagnostic assay developers prioritize mutations for inclusion in their assays. We performed pyrosequencing of seven Mycobacterium tuberculosis gene regions ( katG , inhA , ahpC , rpoB , gyrA , rrs , and eis ) for 1,128 clinical specimens from India, Moldova, and South Africa. We determined the frequencies of each mutation among drug-resistant and -susceptible specimens based on phenotypic drug susceptibility testing results and examined mutation distributions by country. The most common mutation among isoniazid-resistant (INH r ) specimens was the katG 315ACC mutation (87%). However, in the Eastern Cape, INH r specimens had a lower frequency of katG mutations (44%) and higher frequencies of inhA (47%) and ahpC (10%) promoter mutations. The most common mutation among rifampin-resistant (RIF r ) specimens was the rpoB 531TTG mutation (80%). The mutation was common in RIF r specimens in Mumbai (83%) and Moldova (84%) but not the Eastern Cape (17%), where the 516GTC mutation appeared more frequently (57%). The most common mutation among fluoroquinolone-resistant specimens was the gyrA 94GGC mutation (44%). The rrs 1401G mutation was found in 84%, 84%, and 50% of amikacin-resistant, capreomycin-resistant, and kanamycin (KAN)-resistant (KAN r ) specimens, respectively. The eis promoter mutation −12T was found in 26% of KAN r and 4% of KAN-susceptible (KAN s ) specimens. Inclusion of the ahpC and eis promoter gene regions was critical for optimal test sensitivity for the detection of INH resistance in the Eastern Cape and KAN resistance in Moldova. (This study has been registered at ClinicalTrials.gov under registration number NCT02170441.)

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference48 articles.

1. World Health Organization. 2015. Global tuberculosis report 2015. World Health Organization, Geneva, Switzerland.

2. Kent P, Kubica G. 1985. Public health mycobacteriology: a guide for the level III laboratory. US Department of Health and Human Services, Atlanta, GA.

3. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

4. Predicting Extensively Drug-Resistant Mycobacterium tuberculosis Phenotypes with Genetic Mutations

5. Zhang Y, Jacobs WR. 2008. Mechanisms of drug action, drug resistance and drug tolerance in Mycobacterium tuberculosis: expected phenotypes from evolutionary pressures from a highly successful pathogen, p 323–378. In Kaufmann SH, Rubin H (ed), Handbook of tuberculosis. Wiley-VCH Verlag GmbH & Co, Weinheim, Germany.

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3